BAM
IMGN

Bruderman Asset Management’s Immunogen Inc IMGN Stock Holding History

Bruderman Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-500
Closed -$5K – 697
2018
Q3 		$5K Hold
500
– – ﹤0.01% 309
2018
Q2 		$5K Hold
500
– – ﹤0.01% 326
2018
Q1 		$5K Buy
+500
New +$4.94K ﹤0.01% 323

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bruderman Asset Management's IMGN Position: Q4 2018 in Review

Bruderman Asset Management sold out of Immunogen Inc (IMGN) in Q4 2018, closing a stake of 500 shares — an estimated $5K sold.

Bruderman Asset Management first reported a position in IMGN in Q1 2018 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2018.

  • Bruderman Asset Management reported no remaining Immunogen Inc position as of Q4 2018 after selling out during the quarter.
  • Bruderman Asset Management sold 500 Immunogen Inc shares in Q4 2018, an estimated $5K.
  • Bruderman Asset Management first reported a position in Immunogen Inc in Q1 2018 and held it in 3 quarters.
  • Bruderman Asset Management's Immunogen Inc position peaked at $5K in Q3 2018.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2018.

Based on Bruderman Asset Management's 13F filing for Q4 2018, filed 11 Feb 2019.